INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 183 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,071,000 | -74.7% | 6,460 | -63.2% | 0.22% | -72.0% |
| Q2 2015 | $4,241,000 | -13.1% | 17,570 | +1.6% | 0.78% | -11.5% |
| Q1 2015 | $4,879,000 | +62.7% | 17,300 | -10.0% | 0.88% | +146.3% |
| Q4 2014 | $2,998,000 | -73.2% | 19,221 | -59.3% | 0.36% | -46.9% |
| Q3 2014 | $11,169,000 | +579.0% | 47,189 | +578.6% | 0.67% | +817.8% |
| Q2 2014 | $1,645,000 | – | 6,954 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |